Dr. Patel on Sequencing Therapy in Rectal Cancer

Video

In Partnership With:

Timil Patel, MD, discusses an optimal sequencing strategy in rectal cancer.

Timil Patel, MD, clinical fellow in Hematology/Oncology, Yale School of Medicine, discusses an optimal sequencing strategy in rectal cancer.

Following chemotherapy, patients are restaged, and a multidisciplinary tumor board recommends next steps based on the patient’s response to systemic chemotherapy, says Patel.

Generally, chemoradiation is recommended for patients with a single site of disease who responded well to chemotherapy. Subsequently, a tumor board will decide whether radiation or surgical resection is the optimal approach to treat lung nodules, concludes Patel.

Related Videos
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Vikram M. Narayan, MD, assistant professor, Department of Urology, Emory University School of Medicine, Winship Cancer Institute; director, Urologic Oncology, Grady Memorial Hospital
Stephen V. Liu, MD
S. Vincent Rajkumar, MD
Pashtoon Murtaza Kasi, MD, MS
Naseema Gangat, MBBS
Samilia Obeng-Gyasi, MD, MPH,
Kian-Huat Lim, MD, PhD
Saurabh Dahiya, MD, FACP, associate professor, medicine (blood and marrow transplantation and cellular therapy), Stanford University School of Medicine, clinical director, Cancer Cell Therapy, Stanford BMT and Cell Therapy Division
Muhamed Baljevic, MD